Timetable icon Self-scheduling is currently available for select locations!

OCLI Blog – Cutting Edge

January 18, 2009
January 18, 2009

ReSTOR +3.0 Now Available!

I mentioned last month that the FDA approved Alcon’s ReSTOR +3.0 multifocal IOL.  I am pleased the this new IOL is now available for implantation.  In fact, I was able to implant the first one in New Jersey last Wednesday. The clinical studies of the new ReSTOR +3.0, that was submitted to the FDA, showed…

January 5, 2009
January 5, 2009

Latisse -FDA Approved Eyelash Growth Drug

Last week, the FDA has approved Latisse, the first drug to promote eyelash growth, according to Allergan, the company that makes Latisse. Latisse, which will be available by prescription starting in the first quarter of 2009, contains the active ingredient of the glaucoma drug Lumigan, which is also made by Allergan. Eyelash growth is a…

December 26, 2008
December 26, 2008

Alcon Receives FDA Approval for ReSTOR +3.0

  Alcon, Inc. announced the approval of their ReSTOR +3.0 intraocular lens for the treatment of presbyopia following cataract surgery and refractive lens exchange.  This IOL will complement their already approved ReSTOR +4.0. So what does this mean to our refractive cataract patients?  The ReSTOR +4.0 is an excellent multifocal IOL that allows my patients both near…

Services offered at OCLI

Our world-class team of professionals at OCLI can help you with the latest treatment options for you.

Schedule an appointment

Are you a new patient? *